Ani Pharmaceuticals (ANIP)'s 30-day implied volatility (IV30) was 30.0% at the close on November 6, 2026, up from 24.1% the day before, against a 52-week range of 19.4% to 59.4%. Its 20-day historical volatility was 30.0%.
Data as of November 6, 2026.